Fig. 8
From: Gene regulatory networks reveal sex difference in lung adenocarcinoma
Validation of sex-specific therapeutics predicted by CLUEreg using GDSC drug sensitivity data. Boxplots of half maximal inhibitory concentration values (Log IC50) for male and female cell lines treated with Trametinib and Panobinostat, Mann-Whitney test